Gordon Samson, President, Intellectual Property, provides a virtual update on strategy and generative AI initiatives
London, UK – March 20, 2024 Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today the launch of the third and final video in a series of Clarivate in the Age of AI webinar presentations led by the Presidents of its three segments: Academia & Government, Life Sciences & Healthcare and Intellectual Property.
The Intellectual Property (IP) video presentation highlights how Clarivate plays an important role in the IP ecosystem by serving as an indispensable partner to more than 20,000 customers. Clarivate is deeply entrenched across the global IP landscape supporting some of the most critical, non-discretionary tasks in the IP process. Gordon Samson, President, Intellectual Property, discusses the business strategy, how we intend to align our portfolio to the market growth rate, and our artificial intelligence strategy to add more value to our customers. The presentation concludes with three of our product leaders sharing demos of our recent Generative AI innovations.
Samson said: “The growth in intellectual property filings, globalization, and changes in country laws and regulations has increased the complexity of managing all aspects of the IP process. Our cloud-based and on-premises IP management software and managed services help our clients streamline and automate their portfolio management processes, freeing time for strategic activity and decision-making. We have laid the groundwork to deliver greater value to our customers and set ourselves up for improving sustainable growth.”
The Intellectual Property video webinar as well as the previously released Academia & Government and Life Sciences & Healthcare webinars can be accessed HERE.
You may also like…
Enhanced by AI, comprehensive IP management systems are the superior choice
Currently, many organizations are attempting to address their diverse intellectual property (IP) needs by implementing...
The semaglutide saga continues: navigating generic entry and reinforcing patent strategies in Canada
In our July 2025 analysis, “The Semaglutide Story: Highlighting the Need to Maintain Patent Protection in Canada,” we...
Smart AI automation in IP management
Just like websites, smartphones, and open-source software dramatically changed our modern era, artificial intelligence...











